PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
by Herviou, Laurie (Author)
, Kassambara, Alboukadel (Author)
, Boireau, Stéphanie (Author)
, Robert, Nicolas (Author)
, Requirand, Guilhem (Author)
, Müller-Tidow, Carsten (Author)
, Vincent, Laure (Author)
, Seckinger, Anja (Author)
, Goldschmidt, Hartmut (Author)
, Cartron, Guillaume (Author)
, Hose, Dirk (Author)
, Cavalli, Giacomo (Author)
, Moreaux, Jérôme (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource